Lv4
434 积分 2025-05-28 加入
Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?
8天前
已完结
Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer
11天前
已完结
Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer
11天前
已完结
[Expert consensus on folate receptor α immunohistochemical testing in ovarian cancer and its clinical applications (2025 version)]
11天前
已完结
Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score
30天前
已完结
The target atlas for antibody-drug conjugates across solid cancers
30天前
已完结
Exploring Clearance Pathways for GalNAc-siRNAs: Insights into Intracellular Kinetics and Therapeutic Implications
1个月前
已完结
Guanylyl Cyclase 2C–Targeted Chimeric Antigen Receptor T-Cell Therapy in Patients With Metastatic Colorectal Cancer
2个月前
已完结
The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis
3个月前
已完结
MTAP Loss Is Frequent in Oncogene-Driven NSCLC and May Confer Sensitivity to Combined PRMT5 Inhibitors and Targeted Therapies
3个月前
已完结
皖公网安备34019202002308
